Assuta Launches Digital Tool for Breast Cancer Risk Assessment in Israel

New Data on Breast Cancer in Israel

Every week, approximately 113 women in Israel are diagnosed with breast cancer, making it the most common and deadliest cancer among women in the country. According to recent data published by the Israel Cancer Association, about 5,870 women are expected to be diagnosed with breast cancer by the end of 2026, and around 1,100 are expected to die from the disease during the year.

While most women know that early detection can be critical, understanding personal risk factors is not always straightforward. Questions often arise regarding family history, age-related screening frequencies, and other risk factors that should be taken into account.

Assuta Launches Digital Risk Assessment Tool

To help women gain a clearer initial picture of their health status, Assuta has launched Pink Check, a free and anonymous digital questionnaire that enables women to assess their personal risk of developing the disease. The questionnaire is available in four languages and can be accessed easily online.

"Early detection of breast cancer saves lives. We see paramount importance in making screenings accessible to every woman who needs them, in accordance with medical recommendations based on age or risk factors," said Dr. Shani Brosh, Head of Medical Division at Assuta.

The tool aims to identify women who may be at increased risk and direct them for further medical evaluation if necessary. However, the questionnaire does not constitute a medical diagnosis and does not replace mammography, other screening tests, or a doctor's consultation.

Guidance and Routine Monitoring

For cases requiring further examination, patients can utilize Assuta's Yad BeYad program, designed to assist and accompany individuals who receive findings that require additional follow-up. Experts emphasize that the questionnaire is an additional tool for informed decision-making rather than a substitute for routine medical checkups.